Wolong Zhou
Overview
Explore the profile of Wolong Zhou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
261
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lu H, Ai J, Zheng Y, Zhou W, Zhang L, Zhu J, et al.
Cell Death Dis
. 2024 Jun;
15(6):447.
PMID: 38918360
There is a paucity of comprehensive knowledge pertaining to the underlying mechanisms leading to gefitinib resistance in individuals diagnosed NSCLC harboring EGFR-sensitive mutations who inevitably develop resistance to gefitinib treatment...
2.
Liu S, Hu C, Li M, Zhou W, Wang R, Xiao Y
Int J Biol Sci
. 2023 Aug;
19(12):3709-3725.
PMID: 37564195
Lung cancer, as the most commonly diagnosed malignancy, still accounts for the leading cause of cancer-related deaths worldwide. The high rate of mortality and tumor recurrence has prompted clinicians and...
3.
Zhou W, Cheng Y, Li L, Zhang H, Li X, Chang R, et al.
J Pers Med
. 2023 Mar;
13(3).
PMID: 36983664
Background: Although significant progress has been made in immunotherapy for lung adenocarcinoma (LUAD), there is an urgent need to identify effective indicators to screen patients who are suitable for immunotherapy....
4.
Liu Z, Wang W, Zhou Y, Li L, Zhou W
Dis Markers
. 2023 Feb;
2023:5386635.
PMID: 36776923
Lung squamous cell carcinoma (LUSC) has a poor clinical prognosis and lacks effective targeted therapy. This study is aimed at investigating the role of PSMA1 (proteasome subunit alpha type-1) in...
5.
Li L, Cai Q, Wu Z, Li X, Zhou W, Lu L, et al.
Sci Rep
. 2023 Feb;
13(1):2455.
PMID: 36774446
Cuproptosis is a newly form of cell death. Cuproptosis related lncRNA in lung adenocarcinoma (LUAD) has also not been fully elucidated. In the present study, we aimed to construct a...
6.
Yi B, Cheng Y, Chang R, Zhou W, Tang H, Gao Y, et al.
Biosci Rep
. 2023 Jan;
43(2).
PMID: 36633963
Background: The prognostic significance of tumor-associated macrophages (TAMs) in patients with lung cancer (LCa) remains controversial. We therefore conducted the present study to systematically evaluate the role of different TAMs...
7.
Li X, Zhou W, Wang D
J Cell Biochem
. 2022 Sep;
123(12):2066-2078.
PMID: 36169003
Psoriasis is an autoimmune skin disease with poor prognosis. Currently, there is no cure for psoriasis and the pathogenic mechanism of psoriasis remains unclear. Our study aims to explore key...
8.
Liu S, Hu C, Li M, An J, Zhou W, Guo J, et al.
Cell Death Dis
. 2022 Jan;
13(1):70.
PMID: 35064116
Lung cancer is one of the most lethal malignant tumors in the world. The high recurrence and mortality rate make it urgent for scientists and clinicians to find new targets...
9.
Wang W, Han D, Cai Q, Shen T, Dong B, Lewis M, et al.
Nat Commun
. 2022 Jan;
13(1):245.
PMID: 35017531
About 15-20% of breast cancer (BCa) is triple-negative BCa (TNBC), a devastating disease with limited therapeutic options. Aberrations in the PI3K/PTEN signaling pathway are common in TNBC. However, the therapeutic...
10.
Cai Q, Zhou W, Wang W, Dong B, Han D, Shen T, et al.
Sci Adv
. 2021 Nov;
7(46):eabi6439.
PMID: 34767444
Mitogen-activated protein kinase 6 (MAPK6) is an atypical MAPK. Its function in regulating cancer growth remains elusive. Here, we reported that MAPK6 directly activated AKT and induced oncogenic outcomes. MAPK6...